the method performs reliably under routine laboratory conditions and complies with GMP and ICH Q14/Q2(R2) guidelines.
2. Scope
This SOP is applicable to all validated analytical methods developed for drug substances, drug products, raw materials, and intermediates that are to be implemented in the Quality Control laboratory.
3. Responsibilities
- AMD Analyst: Prepares and shares method transfer documentation and reference standards.
- QC Analyst: Executes transfer verification runs and records observations.
- AMD/QC Group Leaders: Coordinate and supervise the transfer activity.
- QA Executive: Reviews transfer protocol and report; approves final documentation.
4. Accountability
The Heads of Analytical Method Development and Quality Control are jointly accountable for the successful execution and documentation of method transfer activities.
5. Procedure
5.1 Pre-Transfer Review
- Confirm that the method is fully validated as per ICH Q2(R1) or Q14 requirements.
- Ensure the following documents are ready:
- Method of analysis (MoA)
- Validation report
- Standard operating procedures
- Reference standards and sample materials
5.2 Method Transfer Planning
- Prepare a Method Transfer Protocol including:
- Transfer approach: Comparative testing or co-validation
- Number of replicates, acceptance criteria, instruments to be used
- List of materials, batch numbers, analysts, timelines
- Get the protocol reviewed by QA and approved prior to execution.
5.3 Execution of Transfer
- Conduct testing in AMD and QC labs in parallel or sequentially.
- Perform at least 6 replicate sample and standard analyses at both sites.
- Compare the following parameters:
- % Assay values
- % RSD of replicate injections
- System suitability criteria (RT, Rs, N, T)
- Document all observations in Annexure-1 and Annexure-2.
5.4 Data Evaluation
- Evaluate transfer success based on:
- Difference in assay between labs ≤ 2.0%
- System suitability passed
- Acceptance criteria met for all key parameters
- Summarize results in Annexure-3: Method Transfer Summary Report.
5.5 Post-Transfer Steps
- QA to review and approve the report.
- Update SOPs in QC lab with the transferred method.
- Train QC analysts and file training records.
6. Abbreviations
- SOP: Standard Operating Procedure
- QC: Quality Control
- AMD: Analytical Method Development
- QA: Quality Assurance
- MoA: Method of Analysis
7. Documents
- Inter-Laboratory Data Sheet – Annexure-1
- System Suitability Log – Annexure-2
- Method Transfer Summary Report – Annexure-3
8. References
- ICH Q14: Analytical Procedure Development
- ICH Q2(R2): Analytical Procedure Validation
- GMP Guidelines – Schedule M (India)
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
| Signature |
|
|
|
| Date |
|
|
|
| Name |
Meenal Deshmukh |
Vikas Trivedi |
Sunita Reddy |
| Designation |
Method Transfer Chemist |
QA Reviewer |
Department Head |
| Department |
AMD |
QA |
Analytical Method Development |
11. Annexures
Annexure-1: Inter-Laboratory Data Sheet
| Parameter |
AMD Lab |
QC Lab |
Difference |
Status |
| % Assay |
98.9% |
99.2% |
0.3% |
Pass |
| % RSD |
0.7% |
0.6% |
– |
Pass |
Annexure-2: System Suitability Log
| Lab |
RT |
Resolution |
Theoretical Plates |
Status |
| AMD |
5.2 |
2.5 |
3200 |
Pass |
| QC |
5.1 |
2.4 |
3100 |
Pass |
Annexure-3: Method Transfer Summary Report
| Method Title |
Assay of Levofloxacin |
| Transfer Date |
18/05/2025 |
| Transfer Type |
Comparative Testing |
| Transfer Status |
Successful |
| Remarks |
All parameters within acceptable range |
Revision History:
| Revision Date |
Revision No. |
Details |
Reason |
Approved By |
| 21/05/2025 |
2.0 |
Aligned with ICH Q14 |
Annual Update |
Sunita Reddy |
| 10/02/2022 |
1.0 |
Initial Release |
New SOP |
QA Head |